These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30905589)

  • 1. Whole-exome sequencing detects mutations in pediatric patients with atypical hemolytic uremic syndrome in Taiwan.
    Tseng MH; Tsai JD; Tsai IJ; Huang SM; Huang JL; Fan WL; Lee HJ; Wu TW; Lin SH
    Clin Chim Acta; 2019 Jul; 494():143-150. PubMed ID: 30905589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome.
    Bu F; Zhang Y; Wang K; Borsa NG; Jones MB; Taylor AO; Takanami E; Meyer NC; Frees K; Thomas CP; Nester C; Smith RJH
    J Am Soc Nephrol; 2018 Dec; 29(12):2809-2819. PubMed ID: 30377230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic Syndrome.
    Mele C; Lemaire M; Iatropoulos P; Piras R; Bresin E; Bettoni S; Bick D; Helbling D; Veith R; Valoti E; Donadelli R; Murer L; Neunhäuserer M; Breno M; Frémeaux-Bacchi V; Lifton R; Remuzzi G; Noris M
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1011-9. PubMed ID: 25854283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome.
    Yun JW; Oh J; Lee KO; Lee SJ; Kim JO; Kim NK; Kim JS; Koh Y; Yoon SS; Yhim HY; Jo SK; Park Y; Lee JE; Park J; Lee JW; Kim SH; Kim HJ; Oh D; ;
    Thromb Res; 2020 Oct; 194():45-53. PubMed ID: 33213850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
    Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA
    J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
    Szarvas N; Szilágyi Á; Csuka D; Takács B; Rusai K; Müller T; Arbeiter K; Réti M; Haris Á; Wagner L; Török S; Kelen K; Szabó AJ; Reusz GS; Morgan BP; Prohászka Z
    Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole exome sequencing revealed a novel homozygous variant in the DGKE catalytic domain: a case report of familial hemolytic uremic syndrome.
    Gholizad-Kolveiri S; Hooman N; Alizadeh R; Hoseini R; Otukesh H; Talebi S; Akouchekian M
    BMC Med Genet; 2020 Aug; 21(1):169. PubMed ID: 32838746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Osborne AJ; Breno M; Borsa NG; Bu F; Frémeaux-Bacchi V; Gale DP; van den Heuvel LP; Kavanagh D; Noris M; Pinto S; Rallapalli PM; Remuzzi G; Rodríguez de Cordoba S; Ruiz A; Smith RJH; Vieira-Martins P; Volokhina E; Wilson V; Goodship THJ; Perkins SJ
    J Immunol; 2018 Apr; 200(7):2464-2478. PubMed ID: 29500241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.
    Bu F; Maga T; Meyer NC; Wang K; Thomas CP; Nester CM; Smith RJ
    J Am Soc Nephrol; 2014 Jan; 25(1):55-64. PubMed ID: 24029428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Genetic Characteristics of Atypical Hemolytic Uremic Syndrome in Children: A Chinese Cohort Study.
    Wu D; Chen J; Ling C; Chen Z; Fan J; Sun Q; Meng Q; Liu X
    Nephron; 2021; 145(4):415-427. PubMed ID: 33873197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
    Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical hemolytic uremic syndrome: Korean pediatric series.
    Lee JM; Park YS; Lee JH; Park SJ; Shin JI; Park YH; Yoo KH; Cho MH; Kim SY; Kim SH; Namgoong MK; Lee SJ; Lee JH; Cho HY; Han KH; Kang HG; Ha IS; Bae JS; Kim NK; Park WY; Cheong HI
    Pediatr Int; 2015 Jun; 57(3):431-8. PubMed ID: 25443527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and outcome of atypical hemolytic-uremic syndrome in Turkish children: a retrospective study between 2010 and 2017, a single-center experience.
    Conkar S; Mir S; Berdeli A
    Iran J Kidney Dis; 2019 Sep; 13(5):316-321. PubMed ID: 31705748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome.
    Walsh PR; Johnson S; Brocklebank V; Salvatore J; Christian M; Kavanagh D
    Am J Kidney Dis; 2018 Feb; 71(2):287-290. PubMed ID: 29248304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel missense mutation in complement factor I predisposes patients to atypical hemolytic uremic syndrome: a case report.
    Wei X; Li J; Zhan X; Tu L; Huang H; Wang Y
    J Med Case Rep; 2022 Mar; 16(1):101. PubMed ID: 35241161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome.
    Fujisawa M; Kato H; Yoshida Y; Usui T; Takata M; Fujimoto M; Wada H; Uchida Y; Kokame K; Matsumoto M; Fujimura Y; Miyata T; Nangaku M
    Clin Exp Nephrol; 2018 Oct; 22(5):1088-1099. PubMed ID: 29511899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report.
    Pollack S; Eisenstein I; Mory A; Paperna T; Ofir A; Baris-Feldman H; Weiss K; Veszeli N; Csuka D; Shemer R; Glaser F; Prohászka Z; Magen D
    Front Immunol; 2021; 12():608604. PubMed ID: 34248927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes.
    Peyvandi F; Rossio R; Ferrari B; Lotta LA; Pontiggia S; Ghiringhelli Borsa N; Pizzuti M; Donadelli R; Piras R; Cugno M; Noris M
    J Thromb Haemost; 2016 Feb; 14(2):340-5. PubMed ID: 26613809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele
    Pouw RB; Gómez Delgado I; López Lera A; Rodríguez de Córdoba S; Wouters D; Kuijpers TW; Sánchez-Corral P
    Front Immunol; 2018; 9():848. PubMed ID: 29740447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.